title: The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study.
abstract: To investigate the role of hepatitis B (HBV) and C viruses (HCV) in hepatocellular carcinoma (HCC) in an HBV endemic area and elucidate the interaction of these two viruses, a case-control study of 128 patients with HCC and 384 age-matched and sex-matched control subjects was done. The positive rates of hepatitis B surface antigen (HBsAg, 77.3%, 99 of 128) and anti-HCV (19.5%, 25 of 128) in patients with HCC were significantly higher than in control subjects (P less than 0.001). Both HBsAg and anti-HCV were important risk factors for HCC (relative risks, 13.96 and 27.12, respectively), and the risk for HCC was elevated significantly to 40.05 (95% confidence interval, 12.57 to 127.6) when HBsAg and anti-HCV were considered simultaneously. These results suggested that HBV and HCV were associated highly with HCC in an HBV endemic area and that these two viruses might contribute independent but synergistic effects to the pathogenesis of HCC.
authors.affiliation: Department of Internal Medicine, Kaohsiung Medical College, Taiwan, Republic of China.
authors.forename: W L
authors.initials: WL
authors.lastname: Chuang
authors.forename: W Y
authors.initials: WY
authors.lastname: Chang
authors.forename: S N
authors.initials: SN
authors.lastname: Lu
authors.forename: W P
authors.initials: WP
authors.lastname: Su
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Lin
authors.forename: S C
authors.initials: SC
authors.lastname: Chen
authors.forename: M Y
authors.initials: MY
authors.lastname: Hsieh
authors.forename: L Y
authors.initials: LY
authors.lastname: Wang
authors.forename: S L
authors.initials: SL
authors.lastname: You
authors.forename: C J
authors.initials: CJ
authors.lastname: Chen
mesh_terms: D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000382:microbiology*; D016022:Case-Control Studies; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000032:analysis; D006509:Hepatitis B / Q000150:complications*; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D013624:Taiwan
chemical_list: D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens